Homocysteine and cognitive function in depression: a systematic review and meta-analysis

Category	Detail
Condition	Depression with cognitive impairment
Key Mechanisms	Association of elevated homocysteine levels with cognitive deficits through neurotoxic effects and oxidative stress.
Target Population	Patients with depression
Care Setting	Clinical and research settings

Significant inverse association between homocysteine levels and cognitive scores (r = −0.41).
High homocysteine levels correlate with poorer cognitive performance (SMD = −0.37).
Patients with cognitive impairment have higher homocysteine levels than cognitively normal individuals (SMD = 2.44).
Further prospective studies are needed to clarify the clinical relevance of homocysteine.
Dysregulation of one-carbon metabolism may affect cognitive function in depression.

Assess homocysteine levels in patients with depression to evaluate cognitive impairment.

Consider monitoring homocysteine levels as part of the management plan for depressed patients with cognitive deficits.

Regularly evaluate cognitive function in patients with elevated homocysteine levels.

Higher homocysteine levels may increase the risk of cognitive decline and dementia.

Individuals diagnosed with depression experiencing cognitive impairment.

Addressing elevated homocysteine levels may be beneficial in managing cognitive deficits in depression.

Utilize validated instruments for diagnosing depression and assessing cognitive function.
Incorporate dietary and lifestyle interventions that may lower homocysteine levels.
Encourage further research into the relationship between homocysteine and cognitive function in depression.

Clinical Scorecard: The Relationship Between Homocysteine Levels and Cognitive Function in Depressed Patients: A Systematic Review and Meta-Analysis